| Name | Title | Contact Details |
|---|
SenoRx, Inc. is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lechnologies Research is a Sussex, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.
EG GILERO is the merger of trusted companies in the medical device industry whose roots go back decades. GILERO Biomedical, Medacys, InField Medical and the medical businesses of eNNOVEA and ValTech Holdings have been brought together by EGI, Inc. to create one vertically integrated resource for the medical device industry. EG GILERO is your single-source, trusted partner for design, development and manufacturing within the medical devices, drug delivery, and primary pharmaceutical packaging markets. With operations in the United States and Asia, EG GILERO is strategically positioned to provide the value added services our clients require in a competitive, ever-changing global marketplace. Together, we will accelerate your device timelines from concept to commercialization.
ARTIO MEDICAL, formerly known as Metactive Medical, is developing innovative endovascular medical devices with the potential to provide immediate and lasting occlusion of aneurysms, blood vessels, and other vascular structures. Artio`s products enable precision placement and provide immediate, complete, and lasting occlusion of target vessel segments and saccular aneurysms. These products will enable physicians to perform better, faster, and safer vascular occlusion procedures.